Qiagen NV | QIA - EPS Earnings Per Share



Qiagen NV reported $0.6 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.5 0.54 Nov/04 2025
FY2025Q2 Jun/2025 0.60 0.53 0.51 Aug/05 2025
FY2025Q1 Mar/2025 0.49 0.47 0.43 May/07 2025
FY2024Q4 Dec/2024 0.59 0.57 0.55 Feb/05 2025
FY2024Q3 Sep/2024 0.54 0.50 0.47 Nov/07 2024
FY2024Q2 Jun/2024 0.51 0.48 0.51 Jul/31 2024
FY2024Q1 Mar/2024 0.43 0.41 0.51 May/07 2024
FY2023Q4 Dec/2023 0.55 0.49 0.53 Feb/06 2024
FY2023Q3 Sep/2023 0.47 0.45 0.53 Oct/30 2023
FY2023Q2 Jun/2023 0.51 0.50 0.51 Aug/08 2023
FY2023Q1 Mar/2023 0.51 0.47 0.80 May/03 2023
FY2022Q4 Dec/2022 0.53 0.48 0.74 Feb/07 2023


Eps Change Date
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
argenx SE USD 3.26 0.99 Jun/2025
Avita Medical USD -0.21 0.05 Dec/2024
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Qiagen NV USD 0.6 0.12 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025